tradingkey.logo

Altimmune Inc <ALT.OQ> expected to post a loss of 36 cents a share - Earnings Preview

ReutersMay 9, 2025 2:24 PM
  • Altimmune Inc ALT.OQ ALT.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Altimmune Inc is for a loss of 36 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Altimmune Inc is $25.00​, above​ its last closing price of $5.80. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.34

-0.33

-0.33

Met

-0.8

Sep. 30 2024

-0.38

-0.35

-0.32

Beat

9.6

Jun. 30 2024

-0.34

-0.34

-0.35

Missed

-2.6​

Mar. 31 2024

-0.36

-0.37

-0.34

Beat

7.4

​​Dec. 31 2023

-0.56

-0.43

-0.33

Beat

23.9

Sep. 30 2023

-0.41

-0.42

-0.39

Beat

8.1​

Jun. 30 2023

-0.45

-0.46

-0.32

Beat

31.1

Mar. 31 2023

-0.48

-0.48

-0.40

Beat

16.6

This summary was machine generated May 9 at 14:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI